Updates on the role of receptor activator of nuclear factor κB/receptor activator of nuclear factor κB ligand/osteoprotegerin pathway in breast cancer risk and treatment. [electronic resource]
Producer: 20171214Description: 4-11 p. digitalISSN:- 1473-656X
- Bone Density Conservation Agents -- pharmacology
- Bone Neoplasms -- drug therapy
- Bone and Bones -- drug effects
- Breast Neoplasms -- genetics
- Chemoprevention
- Denosumab -- pharmacology
- Diphosphonates -- pharmacology
- Female
- Genes, BRCA1 -- physiology
- Humans
- Osteoprotegerin -- metabolism
- RANK Ligand -- antagonists & inhibitors
- Receptor Activator of Nuclear Factor-kappa B -- metabolism
- Risk
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.